Open Access5PSQ-003 Effectiveness and safety of vedolizumab in ulcerative colitis and crohn’s disease
Author(s) -
Laura Villamayor-Belinchón,
Leyre Herrero,
JC de Miguel,
Suzana Deppermann Fortes
Publication year - 2018
Publication title -
section 5: patient safety and quality assurance
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.357
Subject(s) - vedolizumab , medicine , faecal calprotectin , ulcerative colitis , calprotectin , inflammatory bowel disease , crohn's disease , gastroenterology , adverse effect , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom